UK Study Investigates Personalized Pain Management for Endometriosis

LONDON – A new £2.3 million study will examine whether a personalized pain management strategy can improve the quality of life for women living with endometriosis. The research initiative, led by Edinburgh, Birmingham, and Oxford universities, also includes the University of Aberdeen, University College London, and the MRC Centre for Reproductive Health.

Endometriosis affects approximately one in ten women globally. The condition occurs when tissue similar to the lining of the womb grows outside of it, causing chronic pain. Women often report debilitating symptoms, including severe abdominal pain, heavy bleeding, and fatigue.

Dr. Katy Vincent, a senior research fellow at the Nuffield Department of Women’s & Reproductive Health at the University of Oxford, said that current treatment options often involve a trial-and-error approach. She explained that women cycle through various therapies, including hormonal drugs, surgery, and pain medications, without a consistently effective solution. Dr. Vincent noted that the condition significantly impacts women's education, careers, and personal relationships.

Dr. Erin Greaves, a Chancellor's Fellow at the University of Edinburgh's MRC Centre for Reproductive Health, emphasized the pressing need for better non-hormonal and non-surgical treatments. She stated that many women find current options ineffective or experience significant side effects.

Caroline Owens, a patient representative involved in the study, described endometriosis pain as pervasive, impacting physical and mental health. She stated that the pain can disrupt daily activities and lead to social isolation. Owens expressed hope that the study will lead to better treatment options for those with endometriosis.

The study will recruit participants from specialized endometriosis centers and community settings. Researchers will evaluate the effectiveness of the personalized pain management plans over time. They aim to identify approaches that offer more targeted and effective relief for women with the condition.